Journal of Infectious Diseases Advance Access published January 28, 2013
1
sc
rip
t
Role of Interleukin-6 (Il6) in innate immunity to Mycobacterium tuberculosis infection
Alejandra N. Martinez1, Smriti Mehra2, Deepak Kaushal1,3,*
1
Divisions of Bacteriology & Parasitology, Tulane University Health Sciences Center, New
Orleans, LA
2
Division of Microbiology Tulane National Primate Research Center, Covington, LA
3
Department of Microbiology & Immunology, Tulane University Health Sciences Center, New
nu
Corresponding author: Dr. Deepak Kaushal, Associate Professor of Microbiology and
Ma
Immunology, Tulane National Primate Research Center, 18703 Three Rivers Road, Covington,
Ac
c
ep
ted
LA, 70433. Tel: (985)-871-6254; Fax: (985)-871-6390; email: dkaushal@tulane.edu.
© The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of
America. All rights reserved. For Permissions, please e‐mail: journals.permissions@oup.com
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
Orleans, LA
2
Abstract
sc
rip
t
Background. Mycobacterium tuberculosis (Mtb) can grow within the hostile intracellular
environment by actively evading macrophage antibacterial functions. The stress response factor
SigH contributes to this process by modulating -chemokine and Il6 expression. Hence, Il6 is of
critical importance for acquired immunity against TB. Here, we attempted to better characterize
the role of Il6 in the immune response to Mtb infection.
of the Il6 transcript in host macrophages infected with Mtb and Mtb:-sigH. The outcome was
measured by the analysis of bacterial burden and transcriptome-wide analysis of host gene-
Ma
expression. Transcriptome results were confirmed via quantitative PCR and ELISA. Infection of
host macrophages where Il6 had been silenced, with both Mtb and Mtb:-sigH, resulted in
increased expression of interferon-inducible genes, especially those involved in type-1 interferon
signaling. The expression of Ly-6 genes was significantly higher in cells infected with Mtb:∆-
ted
sigH mutant relative to the wild type Mtb (p0.05).
Conclusions/Significance. Mtb regulates host Il6 production to inhibit type I interferonsignaling and, consequently, disease progression. The attenuated mutant Mtb:∆-sigH has a
ep
delayed activation of macrophages compared to the wild type and a delayed inflammatory
stimuli as consequence. These findings have important implications for the better understanding
Ac
c
of the mechanisms behind Mtb virulence and pathogenesis and provide an initial roadmap to
further investigate the mechanisms that may account for the deleterious effects of type I IFN in
Mtb infection.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
Methodology/Principal findings. An siRNA based approach was used to silence the expression
3
INTRODUCTION
sc
rip
t
Resistance to Mycobacterium tuberculosis (Mtb) requires the host to restrict bacterial replication
via a successful Th1 response (1). Hence, pro-inflammatory cytokines and chemokines induced
by Mtb are crucial for immunity to TB. Macrophages play an important role in the innate
immune response to pathogens due to their potent antimicrobial functions and thus, are essential
in shaping adaptive immune responses (2, 3). Nevertheless, Mtb can evade macrophage functions
and actively grow within their hostile intracellular environment (4). As strategy, Mtb inhibits
nu
resists antimicrobial agents that damage the bacterial cell envelope, and counters toxic reactive
Ma
oxygen and nitrogen intermediates (1, 5). The evasion of these innate immune defenses allows
Mtb to replicate within the host and escape early immune detection. Therefore, regulation of
early immune events by pathogens also interferes with the induction of pro-inflammatory
cytokines and consequently, with the disease outcome (2, 6, 7).
ted
Mtb can restrict macrophage activation and pro-inflammatory responses through the
stress response factor SigH (8). Transcriptional comparison of infected macrophages
demonstrated that the Mtb:-sigH mutant strain induced significantly higher levels of Il6 than
ep
Mtb, suggesting its critical importance for acquired immunity against TB. Il6 is a pleiotropic proinflammatory cytokine and its increased production is a hallmark of many human chronic
Ac
c
inflammatory diseases.
Tnf and Il6 are differentially required for protective immune responses in mice infected
with Mtb. However, despite its importance in mediating inflammation, Il6 is not as essential for
anti-mycobacterial effector mechanisms as Tnf (9). Il6 is critical to resistance against TB after
infection with high doses of intravenously delivered Mtb but is dispensable for control of
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
phagosome maturation and acidification, interferes with responses to gamma interferon (Ifng),
4
mycobacterial growth after low dose aerosol infection (10-12). In addition, it has been shown
sc
rip
t
that Il6 is essential for generating protective Th1 immune responses after vaccination with a
subunit vaccine against Mtb (13) but has an inhibitory function with respect to Ifng signaling
(12). Hence, we used a siRNA based approach in attempt to further characterize the role of Il6
and components of the macrophage signaling machinery that regulate intracellular survival of
MATERIALS AND METHODS
Murine cell line and Il-6 siRNA
Ma
Macrophage cell lines derived from C57BL6/J wild type and TLR2-knockout mice were
obtained from BEI Resources (Cat# NR-9456, NR-9457, NR-9567, Manassas, VA) and were
cultured as adherent cells in DMEM supplemented with 10% heat-inactivated FBS under a
humidified 5% CO2 atmosphere as recommended. ON-TARGETplus SMARTpool of four
ted
distinct siRNA species targeting different sequences of the Il6 transcript was obtained from
Dharmacon (Cat# L-043739-00-0005). Pre-designed siRNA obtained from Life Technologies
included GAPDH siRNA (Cat# AM4624) as a positive control, and siRNA with scrambled
ep
sequence as a negative control (Cat# 12935200).
Ac
c
Infection with Mtb and Mtb:-sigH strains
Mtb CDC1551 and Mtb:Δ-sigH mutant strain were cultured as previously described (14, 15).
Bacterial cultures and infection of C57BL/6 at an MOI of 1:10 and after 4 h, the cells were
washed extensively to remove extracellular bacilli (8, 16).
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
Mtb.
5
siRNA transfection
sc
rip
t
Transfection was performed by mixing Il6 siRNA and 1 μl of Lipofectamine™ RNAiMAX
(Invitrogen) for 20 minutes at room temperature. The complex was added to a single well of a 24
well plate, holding 1x105 pre-infected cells per well. Transfections with the positive and negative
controls were performed in parallel. All transfections were undertaken in a final volume of 600
μl with siRNA at a final concentration at 100 nM. Transfections were harvested at 24 or 48 hours
Real-time PCR
Ma
RT-PCR was performed with cDNA corresponding to 100 ng of each independent RNA sample,
using the SYBR green Supermix kit (Applied Biosystems) with specific primers for each target
(Table 1) obtained from PrimerBank (http://pga.mgh.harvard.edu/primerbank/) unless sequence
is specified. Relative expression levels were normalized using 18S rRNA as an invariant
ted
transcript, and data was analyzed using the Δ∆Ct method. The average relative expression levels
and the standard deviations were determined in triplicate.
ep
ELISA and 4-Plex Assay
Supernatants collected from infected and siRNA-treated cells or in medium alone were assayed
by the Mouse Il6 ELISA kit (Invitrogen) according to the manufacturer's instructions.
Ac
c
Supernatants were also used for quantification of secreted Ifng, Il15, Ccl2 and Cxcl10 using the
mouse cytokine 4 milliplex™ map kit (Millipore).
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
post-transfection.
6
DNA Microarray experiments and analysis
sc
rip
t
24 hours post-infection/silencing, host transcripts extracted from ~3×105 cells using the RNeasy
kit (Qiagen), were used to profile the expression of mouse genome using 4×44 mouse
microarrays (Agilent) as described earlier (17-19). Control samples (infected and treated with
negative control siRNA) were labeled with Cy3, whereas experimental samples (infected with
Mtb, Mtb:Δ-sigH and silenced with Il-6 siRNA) were labeled with Cy5. The analysis methods
have previously been described earlier (17-19). Genes whose expression changed by at least 50%
nu
analysis, total transcripts extracted from ~3×105 cells were labeled and hybridized to miRCURY
Ma
LNA™ microRNA Arrays (Exiqon Inc) as described (20).
CFU counts
Intracellular bacteria were obtained by lysing the cells with sterile PBS containing 0.1% saponin
ted
(Sigma). The released bacilli were serially diluted in PBS containing 0.01% Tween-80 (Merck)
and plated on Middlebrook 7H10/OADC agar in triplicate. CFUs were counted after 21 days of
ep
incubation at 37°C.
Statistical analysis
Statistical significance was determined using ANOVA and Mann-Whitney tests in GraphPad
Ac
c
Prism, except for microarray results where a t-test script within Spotfire DecisionSite/S+ Array
Analyzer was used.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
(P<0.05) were considered differentially expressed in a significant manner. For microRNA
7
sc
rip
t
RESULTS
Down-regulation of Il6 mRNA and protein by siRNA delivery in C57BL6/J macrophages cells in
vitro
Real time-PCR and ELISA analysis were performed 24 h after transfection to evaluate the level
of Il6 mRNA and protein expression. GAPDH siRNA was used as the silencing reference
standard. The difference between GAPDH transfected samples and the corresponding negative
nu
GAPDH mRNA by >85% in either Mtb or Mtb-sigH infected cells (data not shown). Similarly,
Ma
the Il6 siRNA induced significant reduction of 49% (FC = -1.98) and 65% (FC = -2.86)
(P < 0.01) in Il6 mRNA levels in macrophages infected with Mtb and Mtb:-sigH, respectively
(Fig 1A). The protein expression levels were also down-regulated by 41% (FC = -1.7) and 47%
(FC = -1.9) (P < 0.05) in Mtb and Mtb:-sigH infected cells, respectively (Fig 1B).
ted
Mtb normally limits the magnitude of Tlr2 activation, thereby preventing robust
activation of macrophage pro-inflammatory responses, including Il-6 (21). Thus, we analyzed the
expression and efficacy of Il6 silencing in Tlr2-/ bone marrow macrophages infected with Mtb.
ep
We found that Il6 expression was severely reduced after infection with wild type Mtb as well as
with the mutant. The residual levels of Il6 mRNA were higher, but not significant, in Mtb:-sigH
Ac
c
infected cells (Fig 1C). Moreover, the silencing effect was very similar to what was found in
wild type infected macrophages. Thus, Il6 mRNA levels were reduced by 47% (FC = -1.88) and
58% (FC= -2.37) (P < 0.01) in Tlr2-/ macrophages infected with Mtb and Mtb:-sigH,
respectively (Fig 1C). These results show that increased signaling through Tlr2 leads to higher
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
control was used to calculate the percent remaining GAPDH mRNA. The siRNA knocked down
8
levels of Il-6 by Mtb:-sigH infected macrophages and suggest that SigH functions by limiting
sc
rip
t
the magnitude of Tlr2-dependent innate immune response.
Despite similar Il6 mRNA levels, Il6 protein levels were significantly lower in Mtb:sigH infected cells compared to Mtb (Fig 1B; p 0.05). Conversely, Mtb:-sigH induced
significant higher levels of Il6 gene expression compared to Mtb (Fig 1A; p 0.05). Thus, since
microRNAs (miRs) regulate protein translation and/or mRNA destabilization we used a
expression profile of miRs from C57BL6/J macrophages infected with Mtb or Mtb:-sigH for 24
hours. From the miRs that were significantly downregulated, let-7a and miR-142-3p directly
Ma
target Il6 (22-24). Here, let-7a and miR-142-3p were down-regulated in cells infected with Mtb,
whereas, only miR-142-3p was found to be significantly down-regulated in cells infected with
Mtb:-sigH (Table 2). Since let-7a and miR-142-3p directly inhibit Il6 (22, 24) we suggest the
ted
down-regulation of both miRs as the mechanism used by the immune system to induce higher
levels of Il6 protein as compared to Mtb:-sigH.
Effect of Il6 knock-down on bacterial growth
ep
In order to analyze whether down-regulation of Il6 might affect an already established infection
with Mtb, macrophages were silenced for 24 and 48 hours. Briefly, C57BL6/J macrophages were
Ac
c
infected for four hours with Mtb or Mtb:-sigH at an MOI of 1:10 and then the expression of Il6
silenced. Compared to the negative scrambled control, administration of Il6 siRNA for 24 hr had
no significant effect on mycobacterial growth for either Mtb strain. However, after 48 hr of
silencing CFUs were found to be significantly increased in both Mtb as well as Mtb:-sigH
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
microRNA array approach to determine if miRs were involved in Il6 regulation. We analyzed the
9
(p < 0.01) (Fig 2). Hence, reduced Il6 expression resulted in increased susceptibility during
sc
rip
t
experimental Mtb infection and indicates that Il6 has an effect on protective immune response.
The global transcriptomic response to Il6 silencing
To study the impact of Il6 on host phagocytes, we compared the transcriptome profiles of
infected C57Bl6/J M silenced for Il6 to those treated with the negative silencing control
considered. Thus, when biological replicates of infected C57bl6/J M silenced for Il6 were
compared to the infected non-silenced control, the expression of 204 genes was induced by Mtb
Ma
infection, while the expression of 313 genes was induced by infection with Mtb:-sigH, by at
least 50% in each of the duplicate experiments. Of these, 141 genes were induced commonly by
infection with either tubercle bacilli.
After 24 hours of silencing, interferon inducible genes showed to be up-regulated by both
ted
Mtb strains (Table 3). However, the expression of these genes was not significantly different in
the mutant compared to the wild type Mtb. In addition, pathway analysis of the expression
profiles showed that the majority of the transcripts were associated with type I Ifnab signaling.
ep
These results demonstrate that Il6 down-regulates interferon responses in murine macrophages
infected with either Mtb or Mtb:∆-sigH and plays an important role in the process that leads to
Ac
c
disease susceptibility.
In order to confirm the results obtained from microarrays we performed quantitative PCR
for type I Ifn pathway genes. The expression of Cxcl10, Ifit1, Ifit2, Rsad2 and Irg1 was
significantly higher in cells infected with either strain of tubercle bacilli, when Il6 expression
was silenced, relative to when the control scrambled RNA was used (Table 3). Conversely, even
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
(scrambled siRNA). Genes that showed an alteration in expression by more than 1.5 fold were
10
though the expression of Il15, Cxcl11 and Ifit3 was up-regulated these findings were not
sc
rip
t
significant.
The expression of three Toll-like receptor (Tlr) genes was differentially regulated
following infection with either Mtb strain. However, the differences between the two strains
were not significant. Hence, the expression of Tlr2, Tlr3 and Tlr4 was induced by 1.93, 1.70,
1.75 fold, respectively by silencing of Il6 in Mtb infected cells and by 2.06, 1.75, 1.62 fold in
those infected with the mutant. Tlrs recognize pathogen-associated molecules, which stimulate
nu
of cells to type I Ifn likely involves up-regulation of caspases and pro-apoptotic innate sensors,
Ma
such as Tlrs and the inflammasomes (21, 25). Thus, our results suggest that the knock down of
Il6 up-regulates type 1 Ifns, which in turn induce Tlrs in a positive feedback manner.
Furthermore, microarray analysis revealed that four genes belonging to the lymphocyte
antigen 6 complex (Ly6) were induced in response to Il6 silencing. In mice, expression of Ly6
ted
locus encodes a family of 10–12 kDa proteins that are linked to the cell surface by a
glycosylphosphatidyl-inositol anchor and have cell signaling and cell adhesion properties (26).
Our results showed that while the expression of all four Ly6 genes was higher in Mtb relative to
ep
the mutant, the expression of Ly6c and Ly6i, but not Ly6a and Ly6f, was higher in a statistically
significant manner (Fig 3A; p0.05). Since Type 1 Ifn is directly involved in Ly6c monocyte
Ac
c
differentiation (27) we, thus, suggest that Ly6 genes might play an important role in host defense
against Mtb infection. Moreover, the expression of the other four genes Cish, Csf1r, Ifitm6 and
Cxcl2, appeared to be significantly different in cells infected with Mtb:∆-sigH mutant relative to
the wild type Mtb, when Il6 expression was silenced (Fig 3B). These genes play crucial roles in
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
the efferent limb of the immune system to secrete cytokines and activate macrophages. Exposure
11
immunity against bacterial and viral infections and in governing the extent of disease progression
sc
rip
t
and severity.
Confirmation of microarray results at the protein level by cytokine/chemokine assay
We performed bead array assays for Cxcl10, IFN-, Ccl2 and Il-15 in the supernatants obtained
from silenced and infected cells with either Mtb strain. IFN- protein levels were not elevated in
chemokine Cxcl10 was increased. Hence, similar to the transcript analysis, silenced macrophages
infected with the mutant induced higher levels of Cxcl10 protein (2.2 fold; p0.05) compared to
Ma
those infected with wild type Mtb (1.5 fold; p>0.05) (Fig. 4A). This result is in accordance to the
in vivo study where Ifna2 and Ifng proteins were not elevated in serum from patients with active
TB, but Cxcl10 was significantly increased (28).
Likewise, even though microarray analysis showed up-regulation of Il15 expression, its
ted
protein levels could not be detected. This result can be explained by the very short in vivo t1/2 of
soluble Il15, as well as the unique mechanism of Il-15 trans-presentation (29). Moreover, since
Ly6c-high monocytes, also known as inflammatory monocytes (Ly6chigh/Ccr2+/Cx3cr1low), have
ep
been shown to be the main producers of Ccl2 in mice (27) and were up regulated in the
microarray studies, we looked at Ccl2 protein expression. Results showed that silencing of Il-6
Ac
c
had no significant effect on Ccl2 protein expression yet, there was a significant difference in the
induction between the two strains. Thus, wild type Mtb induced higher levels of Ccl2 compared
to the mutant Mtb:∆-sigH, when Il6 was silenced (p0.05) (Fig. 4B). This result shows that the
attenuated mutant Mtb:∆-sigH has a delayed activation and recruitment of monocytes to the site
of infection compared to the virulent strain. This is consistent with our in-vivo observations,
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
the supernatant of macrophages infected with Mtb or Mtb:∆-sigH, although the IFN-inducible
12
where incorporation of BrdU in bone-marrow derived monocytes was significantly induced in
sc
rip
t
macaques infected with Mtb, but not Mtb:∆-sigH (18).
DISCUSSION
Mtb interferes with host signaling pathways activated by Ifng (30-32) for its survival. It exploits
Il-6 induction as one of the mechanisms to inhibit Ifng (31). Here, we show that the down-
nu
transcription of Ifn-related genes (Table 3). This result was validated by significantly increased
Ma
qPCR transcript and protein levels of Ifn- inducible chemokine Cxcl10 in silenced macrophages
(Fig 4A). Although Ifng is known to be protective during immune responses to intracellular
pathogens, including mycobacteria the role of type I Ifnab is less clear (25, 33). It has been
shown that activation of type I Ifn signaling is crucial for defense against viral infections but may
ted
be harmful during bacterial, including mycobacterial infections (34-36).
Ifn signaling triggers hematopoietic stem cell proliferation (37) and, thus, mediates
monocyte differentiation (27). A recent report showed that Ifn-I receptor knockout (Ifnar1-/-)
ep
mice developed significant defects in the infiltration of Ccl2-producing Ly6chi monocytes in the
lung after influenza infection (27). Here, we show that despite the enhanced expression of Ly6
related genes in silenced macrophages the difference of Ccl2 protein levels between silenced and
Ac
c
control infected macrophages were not significant (Fig. 4B). Nonetheless, macrophages infected
with virulent Mtb induced higher levels of Ccl2 and had a less effective silencing of Il-6
compared to the attenuated mutant Mtb:∆-sigH. Based on these results and previous in-vivo
observations (18), we conclude that Mtb induces an earlier and more robust macrophage
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
regulation of Il6 in murine macrophages infected with virulent or attenuated Mtb induces
13
activation compared to Mtb:∆-sigH and, thus, partially impairs silencing effectiveness. This
sc
rip
t
differential activation of macrophages likely confers Mtb, as opposed to Mtb:∆-sigH, the ability
to resist host cellular immunity and progress to active disease or to succumb to the host
protective responses.
In this study, silencing of Il6 prompted significant opposite regulatory effects on the
transcript levels of Cxcl2 and Cish in cells infected with Mtb:∆-sigH mutant relative to the Mtb
(Fig 3B). Type I Ifn has been shown to inhibit the production of Cxcl2 during influenza
nu
bacterial infections (25). Here, the down-regulation of Cxcl2 by Mtb:∆-sigH as opposed to the
Ma
up-regulation by Mtb is consistent with the higher protein levels of IFN-inducible chemokine
Cxcl10 presented by Mtb:∆-sigH compared to Mtb infected cells (Fig 4A). On the contrary, Cish
was found to be up-regulated in Mtb:∆-sigH and down-regulated in Mtb infected cells. Cish
SNPs correlate with increased susceptibility to TB (38) and is essential for the maturation of DCs
ted
and the generation of an effective CTL response (39). Hence, it appears that Mtb may utilize
antigens expressed by the SigH regulon during the infection process via yet to be characterized
mechanism(s), to repress the production of Cish. Absence (or reduced expression) of Cish would
ep
thus result in the maintenance of DCs in an immature phase and prevent the accumulation of an
effective CTL response, both of which would be beneficial for the persistence of the pathogen.
Ac
c
The expression of both Ifitm6 and Csf1r was higher upon infection with Mtb:∆-sigH relative to
Mtb infected cells (Fig 3B; p0.05). Ifitm6 belongs to the family of interferon-induced
transmembrane protein and the higher levels of Ifitm6 found in Mtb:∆-sigH infected cells are a
consequence of its more effective silencing. Csf1 and its receptor regulate key effector functions
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
infection, thus decreasing neutrophil recruitment and dampening host defense against secondary
14
of macrophages and contribute to excessive inflammatory responses in sepsis (41). Thus, we
sc
rip
t
suggest that SigH may modulate Csf1r to regulate inflammation.
Our results showed that overexpression of type I Ifnab-inducible transcripts, caused by
the down-regulation of Il6, was concomitant with an increase in bacterial burden after 48 hours
of silencing, indicating disease progression. Similarly, an in vivo study showed that Mtb CFUs in
lungs from C57BL6/J treated with the soluble inhibitor of Il6 trans-signaling (sgp130Fctg) were
slightly but significantly increased after 21 days, but not 14 days, compared to infected control
nu
study that showed increased expression of type I Ifn-inducible transcripts in the blood of patients
Ma
with active tuberculosis (28). In addition, to further substantiate the correlation between disease
severity and increased type I Ifn response there have been reports of TB reactivation during Ifna
treatment for hepatitis C and D viral infection (36, 42).
Modulation of pro-inflammatory responses is highly relevant to Mtb pathogenesisand
ted
here, we show that Mtb dampens Tlr2-dependent pro-inflammatory responses and suggest that
the SigH regulon restricts the onset and magnitude of such responses by limiting Tlr2 activation
in macrophages. In addition, microarray analysis revealed that Tlr2, Tlr3 and Tlr4 were up-
ep
regulated upon Il-6 silencing. Accordingly, many of the pro-inflammatory responses, including
secretion of Il-6 are down-stream of signaling through Tlrs. We therefore suggest that Tlrs are
induced in a positive feedback manner by the knock down of Il6.
Ac
c
Both type I Ifns and Tlr induce Il15 through Myd88 (46). In this study, we provide
evidence that Il15 expression is under transcriptional control of type I interferons and Tlrs, which
in turn are regulated by Il6. Exogenous Il15 increase NK lytic activity and monocytes have
shown to play a regulatory role in NK activation (47). Our microarray experiments showed an
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
mice (9). The deleterious role of type I Ifns in the pathogenesis of TB is corroborated by a recent
15
induction of Il15 upon silencing of Il6, suggesting an indirect effect of Il6 in the activation of NK
sc
rip
t
cells. This hypothesis requires further investigation.
Recently, studies have demonstrated a role for miRs in the regulation of inflammatory
responses (reviewed in 48). Here we used microarray technology to identify miRs that mediate
modulation of Il6. It has been reported that let-7a and miR-142-3p directly inhibit Il6 expression
(22-24). In view of that, we found that Mtb down-regulates both miRs, whereas, Mtb:-sigH
miRs by Mtb, but not Mtb:-sigH, induces higher Il6 gene translation into protein. This posttranscriptional regulation explains the reduced Il6 protein levels presented by Mtb:-sigH
Ma
infected cells compared to Mtb infected cells and suggests compensation as a defense
mechanism. Also, the delayed activation of macrophages infected with Mtb:-sigH results in
reduced subsequent inflammatory stimuli and improved silencing efficiency.
Thus, it appears that macrophages regulate Il6 production to inhibit type I Ifn-signaling
ted
and, consequently, disease progression. Our data indicates that a SigH-dependent Mtb factor
interacts with the host innate immune system to modulate the Il6 levels, leading to disease
susceptibility. These findings have important implications for the better understanding of the
ep
mechanisms behind Mtb virulence and pathogenesis, although, in order to fully understand the
complex signaling network induced by silencing of Il6 additional in vivo experiments are
Ac
c
required. We anticipate that type I IFN acts by increasing the susceptibility of macrophage to
apoptosis-inducing stimuli (Trinchieri, 2010). Hence, our data provides an initial roadmap to
further investigate the mechanisms that may account for the deleterious effects of type I IFN in
Mtb infection.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
down-regulates only miR-142-3p. Thus, we show evidence that the down-regulation of both
16
ACKNOWLEDGEMENTS
sc
rip
t
This work was supported in part by NIH grants: AI089323, HL106790, AI091457, RR026006,
RR020159, RR000164/OD011104 and C06AI058609 as well as awards from the Howard Hughes
Medical Institutes (Kwa-Zulu Natal Research Institute in TB and HIV-AIDS), the Louisiana Vaccine
Center (LVC), the Tulane Research Enhancement Fund, the Tulane Center for Infectious Diseases,
the Office of the Director, TNPRC and a bridge-grant from the Office of the Vice-President for
Professor of Microbiology & Immunology, Tulane National Primate Research Center, 18703 Three
dkaushal@tulane.edu
ted
AUTHOR CONTRIBUTIONS
Ma
Rivers Road, Bldg 20, Covington, LA, 70433. Tel: (985) 871-6224; Fax: (985) 871-6260; email:
Design: ANM, DK; Research: ANM, SM; Data analysis: ANM, SM, DK; Writing: ANM, DK;
ep
Funding: DK.
FOOTNOTES
Ac
c
1. The authors declare no conflict of interest in connection with this manuscript.
2. All procedures were approved by the Tulane Institutional Biosafety Committee (IBC).
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
Research, Tulane University. *Address for correspondence: Dr. Deepak Kaushal, Associate
17
sc
rip
t
REFERENCES
1. Ehrt S, Schnappinger D. 2009. Mycobacterial survival strategies in the phagosome:
defence against host stresses. Cell Microbiol. 11:1170–1178.
2. Bhatt K, Salgame P. 2007. Host innate immune response to Mycobacterium tuberculosis.
J Clin Immunol. 27:347–362.
3. Flannagan RS, Cosio G, Grinstein S. 2009. Antimicrobial mechanisms of phagocytes and
nu
4. Flynn JL, Chan J. 2003. Immune evasion by Mycobacterium tuberculosis: living with the
Ma
enemy. Curr Opin Immunol. 15:450–455.
5. Harding CV, Boom WH. 2010. Regulation of antigen presentation by Mycobacterium
tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol. 8:296–307.
27:393–422.
ted
6. Cooper AM. 2009. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol.
7. Roy CR, Mocarski ES. 2007. Pathogen subversion of cell-intrinsic innate immunity. Nat.
Immunol. 8:1179–1187.
ep
8. Dutta NK, Mehra S, Martinez AN, et al. 2012. The stress-response factor SigH modulates
the interaction between Mycobacterium tuberculosis and host phagocytes. PLoS One.
7(1):e28958.
Ac
c
9. Sodenkamp J, Waetzig GH, Scheller J, et al. 2012. Therapeutic targeting of interleukin-6
trans-signaling does not affect the outcome of experimental tuberculosis.
Immunobiology. In press.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
bacterial evasion strategies. Nat Rev Microbiol.7:355–366.
18
10. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SH. 1997. Lethal
sc
rip
t
tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65: 4843.
11. Saunders BM, Frank AA, Orme IM, Cooper AM. 2000. Interleukin-6 induces early
gamma interferon production in the infected lung but is not required for generation of
specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 68: 3322.
12. Nagabhushanam V, Solache A, Ting LM, Escaron CJ, Zhang JY, Ernst JD. 2003. Innate
inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits
nu
13. Leal IS, Smedegard B, Andersen P, Appelberg R. 1999. Interleukin-6 and interleukin-12
Ma
participate in induction of a type 1 protective T-cell response during vaccination with a
tuberculosis subunit vaccine. Infect. Immun. 67: 5747.
14. Kaushal D, Schroeder BG, Tyagi S, et al. 2002. Reduced immunopathology and mortality
despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative
ted
sigma factor, SigH. Proc Natl Acad Sci USA 11: 8330–8335.
15. Mehra S, Kaushal D. 2009. Functional genomics reveals extended roles of the
Mycobacterium tuberculosis stress response factor sigmaH. J Bacteriol. 191:3965-80.
ep
16. Mehra S, Dutta NK, Mollenkopf HJ, Kaushal D. 2010. Mycobacterium tuberculosis
MT2816 encodes a key stress-response regulator. J Infect Dis. 202(6):943-53.
17. Mehra S, Pahar B, Dutta NK, Conerly CN, Philippi-Falkenstein K, Alvarez X, Kaushal
Ac
c
D. 2010. Transcriptional reprogramming in nonhuman primate (rhesus macaque)
tuberculosis granulomas. PLoS One 5: e12266.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
macrophage responses to IFN-gamma. J Immunol. 171:4750-7.
19
18. Mehra S, Golden NA, Stuckey K, et al. 2012. The Mycobacterium tuberculosis stress
sc
rip
t
response factor SigH is required for bacterial burden as well as immunopathology in
primate lungs. J Infect Dis. 205:1203-13.
19. Gautam A, Dixit S, Philipp MT, Singh SR, Morici LA, Kaushal D, Dennis VA. 2011.
Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi
in macrophages to regulate Lyme disease inflammation. Infect Immun. 79:4876-92.
20. Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, Dash S. 2012. Increased Expression of
nu
Regulated by miR-298. Am J Pathol. 180:2490-503.
Ma
21. Madan-Lala R, Peixoto KV, Re F, Rengarajan J. 2011. Mycobacterium tuberculosis Hip1
dampens macrophage proinflammatory responses by limiting toll-like receptor 2
activation. Infect Immun. 279(12):4828-38.
22. Iliopoulos D, Hirsch HA, Struhl K. 2009. An epigenetic switch involving NF-kappaB,
139(4):693-706.
ted
Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell.
23. Nam Y, Chen C, Gregory RI, Chou JJ, Sliz P. 2011. Molecular basis for interaction of
ep
let-7 microRNAs with Lin28. Cell. 147:1080-91. Epub 2011 Nov 10.
24. Sun Y, Varambally S, Maher CA, Cao Q, Chockley P, Toubai T, Malter C, Nieves E,
Tawara I, Wang Y, Ward PA, Chinnaiyan A, Reddy P. 2011. Targeting of microRNA-
Ac
c
142-3p in dendritic cells regulates endotoxin-induced mortality. Blood. 117:6172-83.
25. Trinchieri G. 2010. Type I interferon: friend or foe? J Exp Med. 207:2053-2063.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is
20
26. Bamezai A. 2004. Mouse Ly-6 proteins and their extended family: markers of cell
sc
rip
t
differentiation and regulators of cell signaling. Arch Immunol Ther Exp (Warsz).
52(4):255-66.
27. Seo SU, Kwon HJ, Ko HJ, et al. 2011. Type I interferon signaling regulates Ly6C(hi)
monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog.
7(2):e1001304.
28. Berry MP, Graham CM, McNab FW, et al. 2010. An interferon-inducible neutrophil-
nu
29. Colpitts SL, Stoklasek TA, Plumlee CR, Obar JJ, Guo C, Lefrançois L. 2012. Cutting
Ma
edge: the role of IFN-α receptor and MyD88 signaling in induction of IL-15 expression in
vivo. J Immunol. 188(6):2483-7.
30. Fortune SM, Solache A, Jaeger A, et al. 2004. Mycobacterium tuberculosis inhibits
macrophage responses to IFN-gamma through myeloid differentiation factor 88-
ted
dependent and -independent mechanisms. J Immunol 172: 6272–6280.
31. Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV. 2003. Inhibition of IFNgamma-induced class II transactivator expression by a 19-kDa lipoprotein from
ep
Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol
171: 175–184.
32. Casanova JL, Abel L. 2002. Genetic dissection of immunity to mycobacteria: the human
Ac
c
model. Annu. Rev. Immunol. 20: 581–620.
33. Decker T, Muller M. & Stockinger, S. 2005. The yin and yang of type I interferon
activity in bacterial infection. Nature Rev Immunol. 5: 675–687.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
driven blood transcriptional signature in human tuberculosis. Nature. 466(7309):973-7.
21
34. Manca C et al, Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs
sc
rip
t
and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon
Cytokine Res. 25, 694–701 (2005).
35. Ordway D et al, The hypervirulent Mycobacterium tuberculosis strain HN878 induces a
potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522–531
(2007).
36. Telesca C, Angelico M, Piccolo P, et al. 2007. Interferon-alpha treatment of hepatitis D
nu
37. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, et al. (2009. IFNalpha
Ma
activates dormant haematopoietic stem cells in vivo. Nature 458: 904–908.
38. Khor CC, Vannberg FO, Chapman SJ, et al. 2010. CISH and susceptibility to infectious
diseases. N Engl J Med. 362:2092-101.
39. Miah MA, Yoon CH, Kim J, Jang J, Seong YR, Bae YS. 2012. CISH is induced during
ted
DC development and regulates DC-mediated CTL activation. Eur J Immunol. 42:58-68.
40. Sadagopal S, Braunstein M, Hager CC, et al. 2009. Reducing the activity and secretion of
microbial antioxidants enhances the immunogenicity of BCG. PLoS One. 4:e5531.
ep
41. Irvine KM, Burns CJ, Wilks AF, Su S, Hume DA, Sweet MJ. 2006. A CSF-1 receptor
kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine
Ac
c
production from murine macrophage populations. FASEB J. 20:1921-3.
42. Sabbatani S, Manfredi R, Marinacci G, Pavoni M, Cristoni L, Chiodo F. 2006.
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated
interferon-alpha and ribavirin for chronic HCV hepatitis. Scand J Infect Dis. 38:205-8.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
induces tuberculosis exacerbation in an immigrant. J. Infect. 54: e223–e226.
22
43. Lopez B, Aguilar D, Orozco H, et al. 2003. A marked difference in pathogenesis and
sc
rip
t
immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp.
Immunol. 133:30–37.
44. Manca C, Reed MB, Freeman S, Mathema B, Kreiswirth B, Barry CE 3rd, Kaplan G..
2004. Differential monocyte activation underlies strain specific Mycobacterium
tuberculosis pathogenesis. Infect. Immun. 72:5511–5514.
45. Reed MB, Domenech P, Manca C, et al. 2004. A glycolipid of hypervirulent tuberculosis
nu
46. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by
Ma
dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and
promotes dendritic cell activation. J. Immunol. 167: 1179–1187.
47. Schierloh P, Alemán M, Yokobori N, Alves L, Roldán N, Abbate E, del C Sasiain M, de
la Barrera S. 2005. NK cell activity in tuberculosis is associated with impaired CD11a
116(4):541-52.
ted
and ICAM-1 expression: a regulatory role of monocytes in NK activation. Immunology.
48. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. 2010. Physiological and
ep
pathological roles for microRNAs in the immune system. Nat Rev Immunol. 10:111-122.
Ac
c
Trinchieri G. 2010. Type I interferon: friend or foe?J Exp Med. 207(10): 2053-2063.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
strains that inhibits the innate immune response. Nature 431:84–87.
23
sc
rip
t
TABLE FOOTNOTES
Table 1. Primer sequences and IDs. This table describes the oligonucleotide sequences for
those mouse DNA-specific primers that were specifically designed by us for quantitative PCR
experiments (Il6, 18S rRNA and Gapdh) as part of this study. Mouse genome specific-primers
Table 2. MicroRNA levels. Cells were infected with Mtb and Mtb:-sigH for 24 hrs and
microRNA levels assessed in total isolated RNA as described in “Materials and Methods”. Here
Ma
we specifically assessed the expression of let-7a and miR-142-3p, two microRNAs that are
known to target Il6. FC indicates difference in fold change in cells infected with either Mtb and
Mtb:-sigH relative to uninfected cells.
ted
Table 3. Key immune function genes which exhibit an elevated expression following Il6
silencing concomitant with either Mtb or Mtb:-sigH infection. The microarray expression
fold-change values of nine key immune function genes are shown following Il6 silencing along
ep
with either infection with either Mtb or Mtb:-sigH, relative to the use of control scrambled
Ac
c
RNA. Quantitative PCR fold-changes and P-values are also shown.
FIGURE LEGENDS
Figure 1. Il6 gene silencing treatment of C57BL6/J macrophages infected with Mtb or
Mtb:-sigH. (A) Wild type cells were incubated in the presence of Il6 siRNA or scrambled
control for 24 h. Il6 induction was evaluated by real-time PCR analysis performed as described
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
were generated for Cxcl10, Cxcl11, Il15, Irg1, Ifit1, 2 and 3 using PrimerBank IDs.
24
in ‘Materials and Methods’ section. (B) Tlr2-/- cells were incubated in the presence of Il6 siRNA
sc
rip
t
or negative scrambled control for 24 hours. (C) Culture supernatants from wild type treated cells
were assayed for Il6 ELISA. The results are the means ± SE of three independent experiments. *,
P < 0.05; ** P < 0.01.
Figure 2. Bacterial burden following treatment with Il6 siRNA in C57BL6/J cells infected
mycobacterial growth for either Mtb strain. After 48 h of silencing, CFUs were found to be
significantly increased in both silenced Mtb strains *, P < 0.05; ** P < 0.01. This figure shows
Ma
the means ± standard deviations for three biological replicates.
Figure 3. Comparison of host immunity gene expression in C57BL6/J macrophages
infected with Mtb or Mtb:-sigH and transfected with Il6 siRNA. (A) Ly6 genes expression
ted
and (B) Cish, Csf1r, Ifitm6, Cxcl2. Expression values are shown for DNA microarray
experiments. Results for Mtb infected cells are represented by green circles, while those for
Mtb:-sigH are represented by the red boxes. Values represent responses that were statistically
Ac
c
P < 0.01.
ep
different between the Il-6 siRNA versus scrambled negative control treatments *, P < 0.05; **
Figure 4. Enhanced induction of Cxcl10 by Il6 siRNA treatment. Macrophages from
C57BL6/J were infected with the wild type Mtb or the Mtb:-sigH mutant strain and transfected
with Il6 siRNA. Supernatants were collected at 24 h post silencing and assayed for (A) Cxcl10
and (B) Ccl2 by a cytokine milliplex™ assay.
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
with Mtb or Mtb:-sigH. Administration of Il6 siRNA for 24 hr had no significant effect on
A
ns
2500
*
***
Mtb
Mtb:Δ‐sigH
2ΔΔ%&
2000
1500
1000
sc
0
***
500
***
***
Ma
pg/mL
400
nu
B
300
200
Ac
ce
pte
d
100
0
Mtb
Mtb:Δ‐sigH
C
ns
ns
4
**
3
2ΔΔ%&
rip
t
500
2
1
0
Mtb
Mtb:Δ‐sigH
Scrambled Ctrl siRNA
IL-6 siRNA
u
s
c
r
i
p
t
a
n
d
M
A
c
c
e
p
t
e
26
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
u
s
c
r
i
p
t
a
n
d
M
A
c
c
e
p
t
e
27
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
u
s
c
r
i
p
t
a
n
d
M
A
c
c
e
p
t
e
28
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
29
Table 1. Primer sequences and ID numbers.
IL-6
PrimerBank ID
Fwd: 5’ CCACGGCCTTCCCTACTTC3’
Rev: 5’ TTGGGAGTGGTATCCTCTGTGA3’
18S rRNA Fwd: 5' TTGACGGAAGGGCACCACCAG 3'
Rev: 5' GCACCACCACCCACGGAATCG 3'
-
-
-
-
Rev: 5’ ACCAGTGGATGCAGGGATGATGTT 3’
-
Rsad2
-
237512932c1
CXCL-10
-
CXCL-11
-
IL-15
-
Irg1
-
Ifit1
-
Ifit2
-
Ifit3
-
nu
-
371940989c1
9507070c1
Ma
363000959c1
ep
Ac
c
950650a1
145301610c3
162461505c1
6754288a1
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
Fwd: 5’ CTTTGGCATTGTGGAAGGGCTCAT 3’
ted
GAPDH
sc
rip
t
Primer sequence
Target
30
Table 2. MicroRNA levels
microRNA
Mtb-∆sigH
FC
FC
let-7a
-2.3
-
miR-142-3p
-2.3
-2.1
Ma
ted
ep
Ac
c
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
nu
sc
rip
t
Mtb
31
Table 3.
FC array
FC array
name
Mtb
Ifit2
Ifit3
Rsad2
Irg1
Mtb:∆sigH
(p‐vaue)
(p‐value)
(p‐value)
(p‐value)
2.83
3.13
2.2
2.7
(0.05)
(0.01)
1.5
1.4
(NS)
(NS)
1.89
1.73
(NS)
(NS)
2.14
2.13
(0.05)
(0.05)
1.76
1.65
2.76
1.92
1.72
2.41
2.35
3.45
2.07
1.53
2.33
2.14
1.60
2.17
1.97
3.05
2.09
1.63
Ac
c
ep
Igtp
Mtb
(0.01)
(0.001)
1.81
1.41
(NS)
(NS)
2.14
2.13
(0.05)
(0.05)
1.91
1.72
(0.001)
(0.001)
ND
ND
Downloaded from http://jid.oxfordjournals.org/ by guest on April 6, 2016
Ifit1
Mtb:∆sigH
nu
IL15
FC qPCR
Ma
Cxcl11
FC qPCR
ted
Cxcl10
FDR
sc
rip
t
Gene